DrugDashboards

Sodium Acetate

Sodium Acetate · SODIUM ACETATE 164 mg/mL · Injection, Solution, Concentrate · Intravenous · Milla Pharmaceuticals Inc.

NDC 71357-0002-10 · 10 VIAL, SINGLE-DOSE in 1 CASE / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.0964per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$83.66per package of 10X20MLGolden State Medical Supply, Inc. · Oct 31, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $88.80 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA214805
TE code
AP
Approval date
May 4, 2021
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)Mar 23, 2016
    month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)Mar 23, 2016
    month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)Feb 3, 2016
    Other
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)Feb 3, 2016
    month 127 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Acetate (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Hospira, Inc.SODIUM ACETATE ANHYDROUS 164 mg/mLJul 15, 2026Sep 3, 2026
Milla Pharmaceuticals Inc.SODIUM ACETATE 164 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCSODIUM ACETATE 4 meq/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.SODIUM ACETATE ANHYDROUS 3.28 g/20mLJul 15, 2026Aug 31, 2026
Amneal Pharmaceuticals Private LimitedSODIUM ACETATE ANHYDROUS 164 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Acetate — NDC 71357-0002-10," retrieved September 3, 2026, https://drugdashboards.com/drug/71357000210.

Free to cite with attribution — see how the data is put together.